🚀 VC round data is live in beta, check it out!
Mauna Kea Technologies Valuation Multiples
Discover revenue and EBITDA valuation multiples for Mauna Kea Technologies and similar public comparables like NeuroOne Medical, Nortech Systems, CytoSorbents, Mentice and more.
Mauna Kea Technologies Overview
About Mauna Kea Technologies
Mauna Kea Technologies SA is a medical device company that develops, manufactures and markets an imaging platform for visualizing tissue at the cellular level, in real time, during standard procedures, with the mission of eliminating uncertainties in diagnosis and treatment through direct visualization of tissue in vivo at the microscopic level. The company’s flagship product, Cellvizio, is the smallest microscope, designed for direct use during minimally invasive procedures. It operates in a single business segment: endomicroscopy. Its geographical presence includes EMEA (Europe, Middle East, Africa), USA and Canada, and Asia with the majority of the revenue deriving from USA and Canada.
Founded
2000
HQ
Employees
65
Website
Sectors
Financials (LTM)
EV
$79M
Mauna Kea Technologies Financials
Mauna Kea Technologies reported last 12-month revenue of $9M and negative EBITDA of ($4M).
In the same LTM period, Mauna Kea Technologies generated ($4M) in EBITDA losses and $10M in net income.
Revenue (LTM)
Mauna Kea Technologies P&L
In the most recent fiscal year, Mauna Kea Technologies reported revenue of $9M and EBITDA of ($9M).
Mauna Kea Technologies expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $9M | XXX | $9M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $8M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 84% | XXX | XXX | XXX |
| EBITDA | ($4M) | XXX | ($9M) | XXX | XXX | XXX |
| EBITDA Margin | (38%) | XXX | (104%) | XXX | XXX | XXX |
| EBIT Margin | (56%) | XXX | (79%) | XXX | XXX | XXX |
| Net Profit | $10M | XXX | ($12M) | XXX | XXX | XXX |
| Net Margin | 109% | XXX | (136%) | XXX | XXX | XXX |
| Net Debt | — | — | $34M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Mauna Kea Technologies Stock Performance
Mauna Kea Technologies has current market cap of $41M, and enterprise value of $79M.
Market Cap Evolution
Mauna Kea Technologies' stock price is $0.21.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $79M | $41M | -4.0% | XXX | XXX | XXX | $-0.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMauna Kea Technologies Valuation Multiples
Mauna Kea Technologies trades at 8.4x EV/Revenue multiple, and (21.9x) EV/EBITDA.
EV / Revenue (LTM)
Mauna Kea Technologies Financial Valuation Multiples
As of April 20, 2026, Mauna Kea Technologies has market cap of $41M and EV of $79M.
Equity research analysts estimate Mauna Kea Technologies' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Mauna Kea Technologies has a P/E ratio of 4.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $41M | XXX | $41M | XXX | XXX | XXX |
| EV (current) | $79M | XXX | $79M | XXX | XXX | XXX |
| EV/Revenue | 8.4x | XXX | 8.7x | XXX | XXX | XXX |
| EV/EBITDA | (21.9x) | XXX | (8.4x) | XXX | XXX | XXX |
| EV/EBIT | (15.1x) | XXX | (11.0x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 10.4x | XXX | XXX | XXX |
| P/E | 4.0x | XXX | (3.3x) | XXX | XXX | XXX |
| EV/FCF | 24.0x | XXX | (10.2x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Mauna Kea Technologies Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Mauna Kea Technologies Margins & Growth Rates
Mauna Kea Technologies' revenue in the last 12 month grew by 14%.
Mauna Kea Technologies' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.2M for the same period.
Mauna Kea Technologies' rule of 40 is (46%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Mauna Kea Technologies' rule of X is (51%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Mauna Kea Technologies Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 14% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | (38%) | XXX | (104%) | XXX | XXX | XXX |
| EBITDA Growth | (16%) | XXX | (63%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (46%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | (51%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 16% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 26% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 46% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 163% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Mauna Kea Technologies Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Mauna Kea Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| NeuroOne Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Nortech Systems | XXX | XXX | XXX | XXX | XXX | XXX |
| CytoSorbents | XXX | XXX | XXX | XXX | XXX | XXX |
| Mentice | XXX | XXX | XXX | XXX | XXX | XXX |
| Diagnostic Medical Systems | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Mauna Kea Technologies M&A Activity
Mauna Kea Technologies acquired XXX companies to date.
Last acquisition by Mauna Kea Technologies was on XXXXXXXX, XXXXX. Mauna Kea Technologies acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Mauna Kea Technologies
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMauna Kea Technologies Investment Activity
Mauna Kea Technologies invested in XXX companies to date.
Mauna Kea Technologies made its latest investment on XXXXXXXX, XXXXX. Mauna Kea Technologies invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Mauna Kea Technologies
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Mauna Kea Technologies
| When was Mauna Kea Technologies founded? | Mauna Kea Technologies was founded in 2000. |
| Where is Mauna Kea Technologies headquartered? | Mauna Kea Technologies is headquartered in France. |
| How many employees does Mauna Kea Technologies have? | As of today, Mauna Kea Technologies has over 65 employees. |
| Is Mauna Kea Technologies publicly listed? | Yes, Mauna Kea Technologies is a public company listed on Euronext Paris. |
| What is the stock symbol of Mauna Kea Technologies? | Mauna Kea Technologies trades under ALMKT ticker. |
| When did Mauna Kea Technologies go public? | Mauna Kea Technologies went public in 2011. |
| Who are competitors of Mauna Kea Technologies? | Mauna Kea Technologies main competitors are NeuroOne Medical, Nortech Systems, CytoSorbents, Mentice. |
| What is the current market cap of Mauna Kea Technologies? | Mauna Kea Technologies' current market cap is $41M. |
| What is the current revenue of Mauna Kea Technologies? | Mauna Kea Technologies' last 12 months revenue is $9M. |
| What is the current revenue growth of Mauna Kea Technologies? | Mauna Kea Technologies revenue growth (NTM/LTM) is 14%. |
| What is the current EV/Revenue multiple of Mauna Kea Technologies? | Current revenue multiple of Mauna Kea Technologies is 8.4x. |
| Is Mauna Kea Technologies profitable? | No, Mauna Kea Technologies is not profitable. |
| What is the current EBITDA of Mauna Kea Technologies? | Mauna Kea Technologies has negative EBITDA and is not profitable. |
| What is Mauna Kea Technologies' EBITDA margin? | Mauna Kea Technologies' last 12 months EBITDA margin is (38%). |
| What is the current EV/EBITDA multiple of Mauna Kea Technologies? | Current EBITDA multiple of Mauna Kea Technologies is (21.9x). |
| What is the current FCF of Mauna Kea Technologies? | Mauna Kea Technologies' last 12 months FCF is $3M. |
| What is Mauna Kea Technologies' FCF margin? | Mauna Kea Technologies' last 12 months FCF margin is 35%. |
| What is the current EV/FCF multiple of Mauna Kea Technologies? | Current FCF multiple of Mauna Kea Technologies is 24.0x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.